Paul Tudor Jones Horizon Therapeutics Public LTD CO Transaction History

Tudor Investment Corp Et Al

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$98.98 - $115.74 $3.89 Million - $4.55 Million	39,331 Added 3.11%	1,303,844 $151 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $18 Million - $20.9 Million	186,368 Added 17.29%	1,264,513 $130 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $46.1 Million - $48.7 Million	429,473 Added 66.21%	1,078,145 $118 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $40.5 Million - $73.8 Million	648,672 New	648,672 $73.8 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $937,872 - $1.37 Million	11,812 New	11,812 $942,000

Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $272,395 - $346,121	-3,152 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $310,661 - $377,956	3,152 New	3,152 $340,000
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $1.02 Million - $1.28 Million	-15,166 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $837,618 - $1.21 Million	15,166 New	15,166 $1.18 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $838,261 - $1.58 Million	-27,757 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $690,316 - $1.07 Million	27,757 New	27,757 $822,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $535,148 - $771,683	-21,044 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $2.99 Million - $3.63 Million	-129,940 Reduced 86.06%	21,044 $573,000
Q2 2019 Aug 14, 2019	SELL	$22.81 - $28.48 $468,540 - $585,007	-20,541 Reduced 11.98%	150,984 $3.63 Million
Q1 2019 May 15, 2019	BUY	$19.49 - $29.01 $3.34 Million - $4.98 Million	171,525 New	171,525 $4.53 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.